Quantify is the leading provider of Nordic RWE, but we are also increasingly being asked to coordinate RWE studies beyond the Nordic countries. Quantify has started a European RWE collaboration with Boehringer Ingelheim to conduct studies in heart […]
Quantify’s Christoph Abé (PhD) was involved in a large-scale study identifying population-level brain changes related to stock market fluctuations using neuroimaging data from the UK Biobank.
The study, published in Nature: Scientific Reports, […]
Want to know more about one of our recent publications? Quantify’s Kirk Geale, Gustaf Ortsäter and Alexander Rieem Dun are co-authors on a recent publication on ”Care Pathways in Atopic Dermatitis”. The study´s objective was to describe […]
Today we finally get to welcome Priyanka Saini who will strengthen our administrative team as Admin / HR Manager at our office in Chandigarh. With 8+ years of experience within […]
Today we are delighted to introduce Tine Iskov Kopp who recently joined our Danish team as Senior Lead Analyst.
Tine has a PhD in molecular epidemiology and extensive experience with designing and […]
Today we are thrilled to introduce Mary (Ellie) Dillon who recently joined our team in Stockholm as Lead Analyst!
Ellie is currently finishing her PhD at Aalto University Business School, Finland, […]
Quantify’s Alexander Rieem Dun and Jonas Banefelt are co-authors on a recent publication on the effects of intensity and adherence to lipid-lowering treatment on the risk of cardiovascular events in patients with […]
We are excited to introduce our new Director Dr. Béranger Lueza who joined our international Modelling, Access and Strategy unit this week. Béranger is based in Stockholm and has more […]
Earlier this week the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) based primarily on real-world evidence (RWE). The decision reflects the increasing importance of real-world data (RWD) […]
